Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Short report

The intestinal fatty acid binding protein-2 Ala54Thr polymorphism is associated with diabetic retinopathy in Chinese population

Authors: Zhu Li, Chang-Lin Ni, Wen-yan Niu, Bao-cheng Chang, Li-Ming Chen

Published in: Diabetology & Metabolic Syndrome | Issue 1/2015

Login to get access

Abstract

Objective

Endothelial dysfunction which is induced by serum saturated fatty acids increasing is one of pathogenesis of diabetic retinopathy (DR). The intestinal fatty acid binding protein-2 (FABP2) Ala54Thr polymorphism results in serum saturated fatty acids elevating. In the present study, we assessed the association of FABP2 gene polymorphism (Ala54Thr) with DR in Chinese population.

Materials/Methods

In this case–control association study, 810 T2DM patients were recruited. 420 patients with retinal neovascularization, microneurysms and hemorrhages were considered as cases (DR) and 390 patients with T2DM and no clinical signs of retinopathy (DNR), were recruited as controls. Genotypes for FABP2(Ala54Thr) polymorphisms were assessed with the PCR-RFLP method.

Results

A significant difference in genotype distribution and allele frequency was observed between cases and controls. Patients with DR had significantly higher frequency of the Ala/Thr + Thr/Thr genotypes compared to DNR group [62.6% vs. 46.2%; OR (95% CI), 1.95 (1.48-2.59); p < 0.001]. The DR group showed a significantly higher frequency of the the Thr allele compared to the DNR group [39.5% vs. 29.4%; OR (95% CI), 1.56 (1.16-2.09); p = 0.003]. Binary logistic analyses showed FFA levels (p = 0.014) and Ala54Thr (p = 0.011) were independent correlates of the presence of DR.

Conclusions

We examined that FABP2 polymophism on the Ala54Thr is significant and independent associated with DR.
Literature
1.
go back to reference See JL, Wong TY, Yeo KT. Trends in the pattern of blindness and major ocular diseases in singapore and asia. Ann Acad Med Singapore. 1998;27(4):540–6.PubMed See JL, Wong TY, Yeo KT. Trends in the pattern of blindness and major ocular diseases in singapore and asia. Ann Acad Med Singapore. 1998;27(4):540–6.PubMed
3.
go back to reference Canani LH, Capp C, Ng DP, Nq DP, Choo SG, Maia AL, et al. The fatty acid-binding protein-2 a54t polymorphism is associated with renal disease in patients with type 2 diabetes. Diabetes. 2005;54(11):3326–30.CrossRefPubMed Canani LH, Capp C, Ng DP, Nq DP, Choo SG, Maia AL, et al. The fatty acid-binding protein-2 a54t polymorphism is associated with renal disease in patients with type 2 diabetes. Diabetes. 2005;54(11):3326–30.CrossRefPubMed
4.
go back to reference Mocking RJ, Lok A, Assies J, Koeter MW, Visser I, Ruhe HG, et al. Ala54thr fatty acid-binding protein 2 (fabp2) polymorphism in recurrent depression: associations with fatty acid concentrations and waist circumference. PLoS One. 2013;8(12):e82980.CrossRefPubMedCentralPubMed Mocking RJ, Lok A, Assies J, Koeter MW, Visser I, Ruhe HG, et al. Ala54thr fatty acid-binding protein 2 (fabp2) polymorphism in recurrent depression: associations with fatty acid concentrations and waist circumference. PLoS One. 2013;8(12):e82980.CrossRefPubMedCentralPubMed
5.
go back to reference Thumser AE, Moore JB, Plant NJ. Fatty acid binding proteins: tissue-specific functions in health and disease. Curr Opin Clin Nutr Metab Care. 2014;17(2):124–9.CrossRefPubMed Thumser AE, Moore JB, Plant NJ. Fatty acid binding proteins: tissue-specific functions in health and disease. Curr Opin Clin Nutr Metab Care. 2014;17(2):124–9.CrossRefPubMed
6.
go back to reference Steer P, Vessby B, Lind L. Endothelial vasodilatory function is related to the proportions of saturated fatty acids and alpha-linolenic acid in young men, but not in women. Eur J Clin Invest. 2003;33(5):390–6.CrossRefPubMed Steer P, Vessby B, Lind L. Endothelial vasodilatory function is related to the proportions of saturated fatty acids and alpha-linolenic acid in young men, but not in women. Eur J Clin Invest. 2003;33(5):390–6.CrossRefPubMed
7.
go back to reference Raza ST, Fatima J, Ahmed F, Abbas S, Zaidi ZH, Singh S, et al. Association of angiotensin-converting enzyme (ace) and fatty acid binding protein 2 (fabp2) genes polymorphism with type 2 diabetes mellitus in northern India. J Renin Angiotensin Aldosterone Syst. 2014;15(4):572–9.CrossRefPubMed Raza ST, Fatima J, Ahmed F, Abbas S, Zaidi ZH, Singh S, et al. Association of angiotensin-converting enzyme (ace) and fatty acid binding protein 2 (fabp2) genes polymorphism with type 2 diabetes mellitus in northern India. J Renin Angiotensin Aldosterone Syst. 2014;15(4):572–9.CrossRefPubMed
8.
go back to reference Noonan JE, Jenkins AJ, Ma JX, Keech AC, Wang JJ, Lamoureux EL. An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes. Diabetes. 2013;62(12):3968–75.CrossRefPubMedCentralPubMed Noonan JE, Jenkins AJ, Ma JX, Keech AC, Wang JJ, Lamoureux EL. An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes. Diabetes. 2013;62(12):3968–75.CrossRefPubMedCentralPubMed
9.
go back to reference Kaidonis G, Mills RA, Landers J, Lake SR, Burdon KP, Craiq JE. Review of the prevalence of diabetic retinopathy in indigenous australians. Clin Experiment Ophthalmol. 2014;42(9):875–82.CrossRefPubMed Kaidonis G, Mills RA, Landers J, Lake SR, Burdon KP, Craiq JE. Review of the prevalence of diabetic retinopathy in indigenous australians. Clin Experiment Ophthalmol. 2014;42(9):875–82.CrossRefPubMed
10.
go back to reference Tousoulis D, Papageorgiou N, Androulakis E, Siasos G, Latsios G, Tentolouris K, et al. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches. J Am Coll Cardiol. 2013;62(8):667–76.CrossRefPubMed Tousoulis D, Papageorgiou N, Androulakis E, Siasos G, Latsios G, Tentolouris K, et al. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches. J Am Coll Cardiol. 2013;62(8):667–76.CrossRefPubMed
11.
go back to reference Perassolo MS, Almeida JC, Pra RL, Mello VD, Maia AL, Moulin CC, et al. Fatty acid composition of serum lipid fractions in type 2 diabetic patients with microalbuminuria. Diabetes Care. 2003;26(3):613–8.CrossRefPubMed Perassolo MS, Almeida JC, Pra RL, Mello VD, Maia AL, Moulin CC, et al. Fatty acid composition of serum lipid fractions in type 2 diabetic patients with microalbuminuria. Diabetes Care. 2003;26(3):613–8.CrossRefPubMed
12.
go back to reference Martinez-Lopez E, Garcia-Garcia MR, Gonzalez-Avalos JM, Maldonado-Gonzalez M, Ruiz-Madrigal B, Vizmanos B, et al. Effect of ala54thr polymorphism of fabp2 on anthropometric and biochemical variables in response to a moderate-fat diet. Nutrition. 2013;29(1):46–51.CrossRefPubMed Martinez-Lopez E, Garcia-Garcia MR, Gonzalez-Avalos JM, Maldonado-Gonzalez M, Ruiz-Madrigal B, Vizmanos B, et al. Effect of ala54thr polymorphism of fabp2 on anthropometric and biochemical variables in response to a moderate-fat diet. Nutrition. 2013;29(1):46–51.CrossRefPubMed
Metadata
Title
The intestinal fatty acid binding protein-2 Ala54Thr polymorphism is associated with diabetic retinopathy in Chinese population
Authors
Zhu Li
Chang-Lin Ni
Wen-yan Niu
Bao-cheng Chang
Li-Ming Chen
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-015-0021-8

Other articles of this Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine